2026 product overview details the nine-ingredient liquid formula, purchase options, ingredient-research limitations and safety considerations.
Prostadine has released its 2026 product overview, providing essential information about its liquid supplement’s ingredients, configurations, and safety considerations.
AVENTURA, Fla., Aug. 22, 2026 — Prostadine announces the release of its 2026 product overview, detailing the liquid supplement’s disclosed ingredients, purchase configurations, refund terms and safety considerations.
→ Prostadine Official Product Page (affiliate link — see disclosure below)
The update arrives as dietary supplement use remains common among U.S. adults. A 2026 JAMA Network Open analysis of National Health and Nutrition Examination Survey data reported that supplement use increased from about 51% in 1999–2000 to about 60% in 2021–2023 (Lam et al., 2026, doi:10.1001/jamanetworkopen.2026.19291). That population-level trend provides category context only and is not evidence for Prostadine.
Product Overview
Prostadine is sold as a liquid dropper supplement. Current seller materials list nine ingredients: nori yaki extract powder, wakame extract, kelp powder, bladderwrack powder, saw palmetto, pomegranate extract, iodine, shilajit and neem. Directions on the current seller page describe two full droppers, approximately 2 mL total, once daily. Consumers should follow the label supplied with the bottle because formulas and directions can change.
→ Prostadine Official Product Page (affiliate link — see disclosure below)
Statement From the Company
“This 2026 overview aims to clarify the disclosed formula and its evidence boundaries, ensuring consumers understand the research context,” said Andrew Ross, Media Relations Manager for this release. “Ingredient-level research can provide useful background, but it should not be interpreted as a clinical trial of the complete Prostadine formula.”
Ingredient Research Overview
The studies below were conducted independently of Prostadine and used specific species, preparations, doses or study populations. They show that the listed ingredients or closely identified preparations have been studied; they do not establish that Prostadine produces the same outcomes.
Nori yaki. A randomized, double-blind, placebo-controlled trial in Nutrients examined Porphyra tenera supplementation and immune-related measures in adults (Jung et al., 2020, doi:10.3390/nu12061642; PMID 32498269). The study used a defined Porphyra preparation, which may differ from the nori yaki material in Prostadine.
Wakame. A randomized crossover trial in Plant Foods for Human Nutrition examined dried Undaria pinnatifida consumed with rice and measured post-meal glucose and insulin responses (Yoshinaga and Mitamura, 2019, doi:10.1007/s11130-019-00763-5; PMID 31418121). The food-format intervention differs from the extract listed for Prostadine.
Kelp. A randomized, double-blind study in Marine Drugs evaluated iodine-reduced Laminaria japonica powder over eight weeks and monitored body composition, lipids and thyroid hormones (Aoe et al., 2021, doi:10.3390/md19070352; PMID 34206160). Its species, preparation and iodine profile are not established as equivalent to Prostadine’s kelp powder.
Bladderwrack. A randomized crossover trial in Nutrients examined 500 mg and 2,000 mg doses of a polyphenol-rich Fucus vesiculosus extract and postprandial glycemic measures (Murray et al., 2018, doi:10.3390/nu10030270; PMID 29495492). That standardized extract differs from an unspecified bladderwrack powder.
Saw palmetto. A randomized controlled trial in BJU International compared 320 mg of a Serenoa repens extract with placebo for 12 weeks in men with benign prostatic hyperplasia and found no significant treatment difference on the primary symptom and flow measures (Willetts et al., 2003, doi:10.1046/j.1464-410x.2003.04316.x; PMID 12887481). This is ingredient-level evidence, not a trial of Prostadine.
Pomegranate. A randomized, double-blind, placebo-controlled study in the Journal of Dietary Supplements evaluated a proprietary blend containing Punica granatum fruit-rind and cocoa-seed extracts in healthy young men (Sreeramaneni et al., 2023, doi:10.1080/19390211.2022.2035037; PMID 35129040). Because the intervention combined ingredients, it cannot isolate pomegranate or establish an outcome for Prostadine.
Iodine. Iodine exposure was specifically monitored in the Aoe et al. kelp trial cited above (Marine Drugs, 2021, doi:10.3390/md19070352). That study used iodine-reduced kelp rather than isolated iodine in the Prostadine formula, so it is cited only as safety-relevant context.
Shilajit. A randomized, double-blind, placebo-controlled study in Andrologia examined purified shilajit at 250 mg twice daily for 90 days in healthy men ages 45 to 55 (Pandit et al., 2016, doi:10.1111/and.12482; PMID 26395129). The purified preparation and dose are not established as equivalent to Prostadine.
Neem. A randomized, double-blind, placebo-controlled study in Diabetes, Metabolic Syndrome and Obesity evaluated a standardized aqueous Azadirachta indica leaf-and-twig extract in adults receiving metformin (Pingali et al., 2020, doi:10.2147/DMSO.S274378; PMID 33244247). The preparation, population and endpoints differ from Prostadine’s general-wellness use.
Safety and Evidence Limits
While individual Prostadine ingredients or related preparations have been studied independently, no published randomized clinical trial of the complete Prostadine formula is cited in this announcement. Evidence quality differs by ingredient, and results from a study using one extract, species or dose should not be transferred to the finished product. The product is a dietary supplement and is not presented as a treatment for benign prostatic hyperplasia, urinary tract infection, prostate cancer or another disease.
The formula combines four seaweed-derived ingredients with added iodine. People with a thyroid disorder, iodine sensitivity, a known seaweed allergy, or prescription medication use should have the current label reviewed by a qualified health professional before use. New, persistent or worsening urinary symptoms should be medically evaluated rather than self-treated with a supplement.
Availability and Pricing
Current seller materials list three purchase options: one bottle at $69, three bottles at $59 each, and six bottles at $49 each, providing a clearer comparison. The seller describes one bottle as approximately a 30-day supply. Consumers should verify the final price, shipping terms and taxes at checkout because commercial terms can change.
→ Prostadine Official Product Page (affiliate link — see disclosure below)
Current seller materials state that purchases are covered by a 60-day money-back guarantee. The product support page identifies ClickBank as the order processor and lists ClickBank order-support numbers of 1-800-390-6035 in the United States and +1 208-345-4245 internationally. Refund eligibility and return procedures are governed by the terms shown at the time of purchase.
Manufacturing and Label Review
Seller materials describe Prostadine as made in the United States under manufacturing controls for dietary supplements. U.S. dietary supplement manufacturing is subject to FDA current good manufacturing practice requirements under 21 CFR Part 111. Facility registration or compliance with manufacturing rules should not be described as FDA approval of a dietary supplement.
Consumers evaluating Prostadine reviews, Prostadine review pages, Prostadine supplement colibrim references or Prostadine colibrim listings may encounter different descriptions of the formula and commercial terms. The current bottle label and checkout disclosures should take priority over older third-party summaries.
Scope of This Announcement
This is a product-information and availability announcement, not a clinical-trial report or medical recommendation. The cited literature concerns individual ingredients or related preparations. It does not demonstrate that the complete formula produces the same results. Readers should compare the information in this release with the current product label, seller terms and cited research before making an independent purchasing decision.
→ Prostadine Official Product Page (affiliate link — see disclosure below)
Disclosures
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. Individual responses to dietary supplements may vary based on factors such as health status and lifestyle.
Affiliate Disclosure: This press release contains affiliate links. The referring publisher or distributor may receive compensation if a purchase is completed after a referral. The commercial relationship does not change the evidence limitations or factual qualifications stated in this announcement.
Editorial Disclosure: Prices, shipping terms, directions, ingredient information and refund terms may change. Consumers should rely on the current product label and checkout terms. References to ingredient research do not constitute proof of efficacy or safety for the finished Prostadine formula.
About Prostadine
Prostadine is a liquid dietary supplement for adult men, available in a dropper format for daily use. The brand’s current public materials focus on a multi-ingredient formula combining marine, botanical and mineral ingredients, together with product-use information, customer support and a 60-day money-back guarantee.
→ Prostadine Official Product Page (affiliate link — see disclosure below)
Media Contact
Andrew Ross
Media Relations Manager
Email: support@prostadine.com (for media inquiries)
Order Support (U.S., ClickBank): 1-800-390-6035
Order Support (International, ClickBank): +1 208-345-4245
Order Processor of Record: Click Sales, Inc. (ClickBank), 1444 S. Entertainment Ave, Suite 410, Boise, ID 83709, USA
Website: getprostadine.com
Source and Distribution
Source: Prostadine
Distributed by: XPR Media
###
For more press release distribution and guest post services, visit TS Newswire.
